At the news
? NEUTRALIMPACT 2/10 144 filed May 15, 2026 at 12:51 ET
Director Timothy Coughlin filed a Form 144 notice to sell 3,250 shares of Travere Therapeutics (TVTX) valued at approximately $141,183. The sale represents a small portion of his holdings and is routine for a director. No material impact expected.
- Director Timothy Coughlin filed Form 144 to sell 3,250 shares of TVTX
- Estimated sale value: $141,182.59
- Shares acquired via restricted stock awards on 11/18/2025
- Sale intended for 05/15/2026 on Nasdaq
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access